nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—CYP2C9—brain cancer	0.557	1	CbGaD
Zidovudine—ABCG2—Carboplatin—brain cancer	0.0424	0.227	CbGbCtD
Zidovudine—CYP3A4—Temozolomide—brain cancer	0.0375	0.2	CbGbCtD
Zidovudine—ABCG2—Etoposide—brain cancer	0.0356	0.191	CbGbCtD
Zidovudine—CYP3A4—Lomustine—brain cancer	0.0319	0.17	CbGbCtD
Zidovudine—CYP2C8—Etoposide—brain cancer	0.019	0.102	CbGbCtD
Zidovudine—ABCB1—Etoposide—brain cancer	0.0128	0.0687	CbGbCtD
Zidovudine—SLC22A8—choroid plexus—brain cancer	0.00805	0.213	CbGeAlD
Zidovudine—CYP3A4—Etoposide—brain cancer	0.0077	0.0412	CbGbCtD
Zidovudine—SLC28A1—endocrine gland—brain cancer	0.00172	0.0456	CbGeAlD
Zidovudine—TERT—endocrine gland—brain cancer	0.00169	0.0448	CbGeAlD
Zidovudine—TERT—head—brain cancer	0.00167	0.0442	CbGeAlD
Zidovudine—TERT—central nervous system—brain cancer	0.00152	0.0404	CbGeAlD
Zidovudine—TERT—brain—brain cancer	0.00121	0.032	CbGeAlD
Zidovudine—TK1—endocrine gland—brain cancer	0.00116	0.0308	CbGeAlD
Zidovudine—TK1—head—brain cancer	0.00115	0.0304	CbGeAlD
Zidovudine—TK1—central nervous system—brain cancer	0.00105	0.0278	CbGeAlD
Zidovudine—SLC29A2—endocrine gland—brain cancer	0.000961	0.0255	CbGeAlD
Zidovudine—SLC29A2—cerebellum—brain cancer	0.000847	0.0224	CbGeAlD
Zidovudine—TK1—brain—brain cancer	0.000832	0.022	CbGeAlD
Zidovudine—ABCC5—telencephalon—brain cancer	0.000823	0.0218	CbGeAlD
Zidovudine—SLC29A2—brain—brain cancer	0.000688	0.0182	CbGeAlD
Zidovudine—ABCC5—pituitary gland—brain cancer	0.00067	0.0178	CbGeAlD
Zidovudine—UGT2B7—endocrine gland—brain cancer	0.000649	0.0172	CbGeAlD
Zidovudine—ABCC5—medulla oblongata—brain cancer	0.000647	0.0171	CbGeAlD
Zidovudine—SLC22A11—endocrine gland—brain cancer	0.000633	0.0168	CbGeAlD
Zidovudine—SLC22A7—endocrine gland—brain cancer	0.000618	0.0164	CbGeAlD
Zidovudine—ABCC5—midbrain—brain cancer	0.000591	0.0157	CbGeAlD
Zidovudine—Phlebitis—Etoposide—brain cancer	0.000509	0.00334	CcSEcCtD
Zidovudine—Anaemia—Procarbazine—brain cancer	0.000504	0.00331	CcSEcCtD
Zidovudine—Breast disorder—Temozolomide—brain cancer	0.000495	0.00325	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000493	0.00324	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000493	0.00324	CcSEcCtD
Zidovudine—Dysphagia—Carmustine—brain cancer	0.00049	0.00322	CcSEcCtD
Zidovudine—Syncope—Procarbazine—brain cancer	0.000489	0.00322	CcSEcCtD
Zidovudine—Leukopenia—Procarbazine—brain cancer	0.000488	0.00321	CcSEcCtD
Zidovudine—Cardiac failure congestive—Etoposide—brain cancer	0.000483	0.00318	CcSEcCtD
Zidovudine—Loss of consciousness—Procarbazine—brain cancer	0.000479	0.00315	CcSEcCtD
Zidovudine—Cough—Procarbazine—brain cancer	0.000476	0.00313	CcSEcCtD
Zidovudine—Dysphagia—Temozolomide—brain cancer	0.000473	0.00311	CcSEcCtD
Zidovudine—Convulsion—Procarbazine—brain cancer	0.000473	0.00311	CcSEcCtD
Zidovudine—Pancytopenia—Carmustine—brain cancer	0.000465	0.00306	CcSEcCtD
Zidovudine—Myalgia—Procarbazine—brain cancer	0.000464	0.00305	CcSEcCtD
Zidovudine—Arthralgia—Procarbazine—brain cancer	0.000464	0.00305	CcSEcCtD
Zidovudine—Anxiety—Procarbazine—brain cancer	0.000463	0.00304	CcSEcCtD
Zidovudine—Sweating increased—Temozolomide—brain cancer	0.000461	0.00303	CcSEcCtD
Zidovudine—Neutropenia—Carmustine—brain cancer	0.000458	0.00301	CcSEcCtD
Zidovudine—ABCC5—cerebellum—brain cancer	0.000457	0.0121	CbGeAlD
Zidovudine—Pancytopenia—Temozolomide—brain cancer	0.000449	0.00295	CcSEcCtD
Zidovudine—Confusional state—Procarbazine—brain cancer	0.000449	0.00295	CcSEcCtD
Zidovudine—Vomiting—Lomustine—brain cancer	0.000446	0.00293	CcSEcCtD
Zidovudine—Oedema—Procarbazine—brain cancer	0.000445	0.00293	CcSEcCtD
Zidovudine—Dysuria—Temozolomide—brain cancer	0.000443	0.00291	CcSEcCtD
Zidovudine—Neutropenia—Temozolomide—brain cancer	0.000443	0.00291	CcSEcCtD
Zidovudine—SLC22A7—brain—brain cancer	0.000442	0.0117	CbGeAlD
Zidovudine—Shock—Procarbazine—brain cancer	0.000438	0.00288	CcSEcCtD
Zidovudine—Pollakiuria—Temozolomide—brain cancer	0.000437	0.00287	CcSEcCtD
Zidovudine—Thrombocytopenia—Procarbazine—brain cancer	0.000436	0.00286	CcSEcCtD
Zidovudine—Chills—Hydroxyurea—brain cancer	0.000435	0.00286	CcSEcCtD
Zidovudine—Hyperhidrosis—Procarbazine—brain cancer	0.00043	0.00283	CcSEcCtD
Zidovudine—Weight decreased—Temozolomide—brain cancer	0.000428	0.00281	CcSEcCtD
Zidovudine—Neuropathy peripheral—Carmustine—brain cancer	0.000428	0.00281	CcSEcCtD
Zidovudine—SLC22A6—brain—brain cancer	0.000427	0.0113	CbGeAlD
Zidovudine—Stomatitis—Carmustine—brain cancer	0.000426	0.0028	CcSEcCtD
Zidovudine—Anorexia—Procarbazine—brain cancer	0.000424	0.00279	CcSEcCtD
Zidovudine—Erythema—Hydroxyurea—brain cancer	0.000422	0.00277	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000418	0.00275	CcSEcCtD
Zidovudine—Nausea—Lomustine—brain cancer	0.000416	0.00274	CcSEcCtD
Zidovudine—Neuropathy peripheral—Temozolomide—brain cancer	0.000414	0.00272	CcSEcCtD
Zidovudine—Stomatitis—Temozolomide—brain cancer	0.000411	0.0027	CcSEcCtD
Zidovudine—CYP2A6—cerebellum—brain cancer	0.00041	0.0109	CbGeAlD
Zidovudine—ABCB1—blood vessel—brain cancer	0.000409	0.0109	CbGeAlD
Zidovudine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000406	0.00267	CcSEcCtD
Zidovudine—ABCG2—telencephalon—brain cancer	0.000403	0.0107	CbGeAlD
Zidovudine—Insomnia—Procarbazine—brain cancer	0.000403	0.00265	CcSEcCtD
Zidovudine—Paraesthesia—Procarbazine—brain cancer	0.0004	0.00263	CcSEcCtD
Zidovudine—Hepatobiliary disease—Temozolomide—brain cancer	0.000399	0.00262	CcSEcCtD
Zidovudine—Sinusitis—Temozolomide—brain cancer	0.000396	0.0026	CcSEcCtD
Zidovudine—Somnolence—Procarbazine—brain cancer	0.000396	0.0026	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000395	0.00259	CcSEcCtD
Zidovudine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000392	0.00257	CcSEcCtD
Zidovudine—Anaemia—Hydroxyurea—brain cancer	0.00039	0.00256	CcSEcCtD
Zidovudine—Decreased appetite—Procarbazine—brain cancer	0.000387	0.00254	CcSEcCtD
Zidovudine—Connective tissue disorder—Carmustine—brain cancer	0.000385	0.00253	CcSEcCtD
Zidovudine—Fatigue—Procarbazine—brain cancer	0.000384	0.00252	CcSEcCtD
Zidovudine—Malaise—Hydroxyurea—brain cancer	0.000381	0.0025	CcSEcCtD
Zidovudine—Constipation—Procarbazine—brain cancer	0.000381	0.0025	CcSEcCtD
Zidovudine—Pain—Procarbazine—brain cancer	0.000381	0.0025	CcSEcCtD
Zidovudine—Hepatitis—Temozolomide—brain cancer	0.000379	0.00249	CcSEcCtD
Zidovudine—Dysphagia—Etoposide—brain cancer	0.000379	0.00249	CcSEcCtD
Zidovudine—Leukopenia—Hydroxyurea—brain cancer	0.000378	0.00248	CcSEcCtD
Zidovudine—Pharyngitis—Temozolomide—brain cancer	0.000376	0.00247	CcSEcCtD
Zidovudine—Urinary tract disorder—Temozolomide—brain cancer	0.000374	0.00246	CcSEcCtD
Zidovudine—Connective tissue disorder—Temozolomide—brain cancer	0.000372	0.00245	CcSEcCtD
Zidovudine—ABCC5—brain—brain cancer	0.000371	0.00985	CbGeAlD
Zidovudine—Urethral disorder—Temozolomide—brain cancer	0.000371	0.00244	CcSEcCtD
Zidovudine—Sweating increased—Etoposide—brain cancer	0.000369	0.00242	CcSEcCtD
Zidovudine—Feeling abnormal—Procarbazine—brain cancer	0.000367	0.00241	CcSEcCtD
Zidovudine—Convulsion—Hydroxyurea—brain cancer	0.000366	0.0024	CcSEcCtD
Zidovudine—Gastrointestinal pain—Procarbazine—brain cancer	0.000364	0.00239	CcSEcCtD
Zidovudine—ABCC4—endocrine gland—brain cancer	0.00036	0.00954	CbGeAlD
Zidovudine—Pancytopenia—Etoposide—brain cancer	0.00036	0.00236	CcSEcCtD
Zidovudine—Erythema multiforme—Temozolomide—brain cancer	0.000358	0.00235	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000357	0.00235	CcSEcCtD
Zidovudine—ABCC4—head—brain cancer	0.000355	0.00942	CbGeAlD
Zidovudine—Discomfort—Hydroxyurea—brain cancer	0.000355	0.00233	CcSEcCtD
Zidovudine—Neutropenia—Etoposide—brain cancer	0.000354	0.00233	CcSEcCtD
Zidovudine—Urticaria—Procarbazine—brain cancer	0.000354	0.00232	CcSEcCtD
Zidovudine—SLC22A8—head—brain cancer	0.000352	0.00934	CbGeAlD
Zidovudine—Body temperature increased—Procarbazine—brain cancer	0.000352	0.00231	CcSEcCtD
Zidovudine—Abdominal pain—Procarbazine—brain cancer	0.000352	0.00231	CcSEcCtD
Zidovudine—Cardiac disorder—Temozolomide—brain cancer	0.000352	0.00231	CcSEcCtD
Zidovudine—Oedema—Hydroxyurea—brain cancer	0.000345	0.00226	CcSEcCtD
Zidovudine—Mental disorder—Carmustine—brain cancer	0.000343	0.00226	CcSEcCtD
Zidovudine—Mediastinal disorder—Temozolomide—brain cancer	0.000341	0.00224	CcSEcCtD
Zidovudine—Malnutrition—Carmustine—brain cancer	0.000341	0.00224	CcSEcCtD
Zidovudine—Erythema—Carmustine—brain cancer	0.000341	0.00224	CcSEcCtD
Zidovudine—Chills—Temozolomide—brain cancer	0.00034	0.00223	CcSEcCtD
Zidovudine—Nervous system disorder—Hydroxyurea—brain cancer	0.000338	0.00222	CcSEcCtD
Zidovudine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000337	0.00222	CcSEcCtD
Zidovudine—CYP2C8—pituitary gland—brain cancer	0.000337	0.00894	CbGeAlD
Zidovudine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000335	0.0022	CcSEcCtD
Zidovudine—Skin disorder—Hydroxyurea—brain cancer	0.000335	0.0022	CcSEcCtD
Zidovudine—CYP2A6—brain—brain cancer	0.000333	0.00883	CbGeAlD
Zidovudine—Mental disorder—Temozolomide—brain cancer	0.000332	0.00218	CcSEcCtD
Zidovudine—Neuropathy peripheral—Etoposide—brain cancer	0.000331	0.00218	CcSEcCtD
Zidovudine—Back pain—Carmustine—brain cancer	0.00033	0.00217	CcSEcCtD
Zidovudine—Malnutrition—Temozolomide—brain cancer	0.00033	0.00217	CcSEcCtD
Zidovudine—Erythema—Temozolomide—brain cancer	0.00033	0.00217	CcSEcCtD
Zidovudine—Jaundice—Etoposide—brain cancer	0.000329	0.00216	CcSEcCtD
Zidovudine—Stomatitis—Etoposide—brain cancer	0.000329	0.00216	CcSEcCtD
Zidovudine—Anorexia—Hydroxyurea—brain cancer	0.000328	0.00216	CcSEcCtD
Zidovudine—ABCG2—pituitary gland—brain cancer	0.000328	0.00869	CbGeAlD
Zidovudine—ABCC4—central nervous system—brain cancer	0.000324	0.0086	CbGeAlD
Zidovudine—Dysgeusia—Temozolomide—brain cancer	0.000323	0.00212	CcSEcCtD
Zidovudine—SLC22A8—central nervous system—brain cancer	0.000322	0.00853	CbGeAlD
Zidovudine—Tremor—Carmustine—brain cancer	0.00032	0.0021	CcSEcCtD
Zidovudine—Asthenia—Procarbazine—brain cancer	0.000319	0.0021	CcSEcCtD
Zidovudine—Hepatobiliary disease—Etoposide—brain cancer	0.000319	0.0021	CcSEcCtD
Zidovudine—Back pain—Temozolomide—brain cancer	0.000319	0.0021	CcSEcCtD
Zidovudine—ABCG2—medulla oblongata—brain cancer	0.000316	0.00839	CbGeAlD
Zidovudine—Anaemia—Carmustine—brain cancer	0.000315	0.00207	CcSEcCtD
Zidovudine—Agranulocytosis—Etoposide—brain cancer	0.000315	0.00207	CcSEcCtD
Zidovudine—Pruritus—Procarbazine—brain cancer	0.000315	0.00207	CcSEcCtD
Zidovudine—Tremor—Temozolomide—brain cancer	0.000309	0.00203	CcSEcCtD
Zidovudine—Dyspnoea—Hydroxyurea—brain cancer	0.000307	0.00202	CcSEcCtD
Zidovudine—Somnolence—Hydroxyurea—brain cancer	0.000306	0.00201	CcSEcCtD
Zidovudine—Ill-defined disorder—Temozolomide—brain cancer	0.000306	0.00201	CcSEcCtD
Zidovudine—Leukopenia—Carmustine—brain cancer	0.000305	0.00201	CcSEcCtD
Zidovudine—Anaemia—Temozolomide—brain cancer	0.000305	0.002	CcSEcCtD
Zidovudine—Diarrhoea—Procarbazine—brain cancer	0.000305	0.002	CcSEcCtD
Zidovudine—Dyspepsia—Hydroxyurea—brain cancer	0.000303	0.00199	CcSEcCtD
Zidovudine—Angioedema—Temozolomide—brain cancer	0.000301	0.00198	CcSEcCtD
Zidovudine—Decreased appetite—Hydroxyurea—brain cancer	0.000299	0.00197	CcSEcCtD
Zidovudine—Urinary tract disorder—Etoposide—brain cancer	0.000299	0.00197	CcSEcCtD
Zidovudine—CYP2C19—endocrine gland—brain cancer	0.000299	0.00794	CbGeAlD
Zidovudine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000297	0.00196	CcSEcCtD
Zidovudine—Malaise—Temozolomide—brain cancer	0.000297	0.00195	CcSEcCtD
Zidovudine—Urethral disorder—Etoposide—brain cancer	0.000297	0.00195	CcSEcCtD
Zidovudine—Fatigue—Hydroxyurea—brain cancer	0.000297	0.00195	CcSEcCtD
Zidovudine—Vertigo—Temozolomide—brain cancer	0.000296	0.00195	CcSEcCtD
Zidovudine—Convulsion—Carmustine—brain cancer	0.000296	0.00194	CcSEcCtD
Zidovudine—Leukopenia—Temozolomide—brain cancer	0.000295	0.00194	CcSEcCtD
Zidovudine—Constipation—Hydroxyurea—brain cancer	0.000295	0.00194	CcSEcCtD
Zidovudine—Pain—Hydroxyurea—brain cancer	0.000295	0.00194	CcSEcCtD
Zidovudine—Dizziness—Procarbazine—brain cancer	0.000294	0.00193	CcSEcCtD
Zidovudine—Chest pain—Carmustine—brain cancer	0.000291	0.00191	CcSEcCtD
Zidovudine—Myalgia—Carmustine—brain cancer	0.000291	0.00191	CcSEcCtD
Zidovudine—Anxiety—Carmustine—brain cancer	0.00029	0.0019	CcSEcCtD
Zidovudine—ABCG2—midbrain—brain cancer	0.000289	0.00767	CbGeAlD
Zidovudine—Cough—Temozolomide—brain cancer	0.000288	0.00189	CcSEcCtD
Zidovudine—Erythema multiforme—Etoposide—brain cancer	0.000287	0.00188	CcSEcCtD
Zidovudine—Convulsion—Temozolomide—brain cancer	0.000286	0.00188	CcSEcCtD
Zidovudine—Feeling abnormal—Hydroxyurea—brain cancer	0.000284	0.00187	CcSEcCtD
Zidovudine—Vomiting—Procarbazine—brain cancer	0.000283	0.00186	CcSEcCtD
Zidovudine—ABCG2—spinal cord—brain cancer	0.000282	0.00748	CbGeAlD
Zidovudine—Cardiac disorder—Etoposide—brain cancer	0.000281	0.00185	CcSEcCtD
Zidovudine—Confusional state—Carmustine—brain cancer	0.000281	0.00185	CcSEcCtD
Zidovudine—Myalgia—Temozolomide—brain cancer	0.000281	0.00185	CcSEcCtD
Zidovudine—Arthralgia—Temozolomide—brain cancer	0.000281	0.00185	CcSEcCtD
Zidovudine—Rash—Procarbazine—brain cancer	0.000281	0.00184	CcSEcCtD
Zidovudine—Dermatitis—Procarbazine—brain cancer	0.00028	0.00184	CcSEcCtD
Zidovudine—Anxiety—Temozolomide—brain cancer	0.00028	0.00184	CcSEcCtD
Zidovudine—Headache—Procarbazine—brain cancer	0.000279	0.00183	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000279	0.00183	CcSEcCtD
Zidovudine—Oedema—Carmustine—brain cancer	0.000279	0.00183	CcSEcCtD
Zidovudine—Discomfort—Temozolomide—brain cancer	0.000277	0.00182	CcSEcCtD
Zidovudine—Mediastinal disorder—Etoposide—brain cancer	0.000273	0.0018	CcSEcCtD
Zidovudine—Thrombocytopenia—Carmustine—brain cancer	0.000273	0.00179	CcSEcCtD
Zidovudine—Body temperature increased—Hydroxyurea—brain cancer	0.000272	0.00179	CcSEcCtD
Zidovudine—Chills—Etoposide—brain cancer	0.000272	0.00179	CcSEcCtD
Zidovudine—Confusional state—Temozolomide—brain cancer	0.000271	0.00178	CcSEcCtD
Zidovudine—Oedema—Temozolomide—brain cancer	0.000269	0.00177	CcSEcCtD
Zidovudine—Anaphylactic shock—Temozolomide—brain cancer	0.000269	0.00177	CcSEcCtD
Zidovudine—ALB—brain—brain cancer	0.000266	0.00705	CbGeAlD
Zidovudine—Anorexia—Carmustine—brain cancer	0.000265	0.00175	CcSEcCtD
Zidovudine—Nausea—Procarbazine—brain cancer	0.000264	0.00174	CcSEcCtD
Zidovudine—Nervous system disorder—Temozolomide—brain cancer	0.000264	0.00173	CcSEcCtD
Zidovudine—Thrombocytopenia—Temozolomide—brain cancer	0.000264	0.00173	CcSEcCtD
Zidovudine—Skin disorder—Temozolomide—brain cancer	0.000261	0.00172	CcSEcCtD
Zidovudine—CYP2C8—endocrine gland—brain cancer	0.000261	0.00693	CbGeAlD
Zidovudine—Hyperhidrosis—Temozolomide—brain cancer	0.00026	0.00171	CcSEcCtD
Zidovudine—Dysgeusia—Etoposide—brain cancer	0.000258	0.0017	CcSEcCtD
Zidovudine—ABCC4—brain—brain cancer	0.000257	0.00683	CbGeAlD
Zidovudine—Anorexia—Temozolomide—brain cancer	0.000257	0.00169	CcSEcCtD
Zidovudine—SLC22A8—brain—brain cancer	0.000255	0.00677	CbGeAlD
Zidovudine—Back pain—Etoposide—brain cancer	0.000255	0.00168	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000254	0.00167	CcSEcCtD
Zidovudine—Muscle spasms—Etoposide—brain cancer	0.000254	0.00167	CcSEcCtD
Zidovudine—Insomnia—Carmustine—brain cancer	0.000252	0.00166	CcSEcCtD
Zidovudine—Paraesthesia—Carmustine—brain cancer	0.00025	0.00164	CcSEcCtD
Zidovudine—Dyspnoea—Carmustine—brain cancer	0.000248	0.00163	CcSEcCtD
Zidovudine—Somnolence—Carmustine—brain cancer	0.000248	0.00163	CcSEcCtD
Zidovudine—Asthenia—Hydroxyurea—brain cancer	0.000247	0.00162	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000245	0.00161	CcSEcCtD
Zidovudine—Ill-defined disorder—Etoposide—brain cancer	0.000245	0.00161	CcSEcCtD
Zidovudine—Anaemia—Etoposide—brain cancer	0.000244	0.0016	CcSEcCtD
Zidovudine—Insomnia—Temozolomide—brain cancer	0.000243	0.0016	CcSEcCtD
Zidovudine—Decreased appetite—Carmustine—brain cancer	0.000242	0.00159	CcSEcCtD
Zidovudine—Paraesthesia—Temozolomide—brain cancer	0.000242	0.00159	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Carmustine—brain cancer	0.00024	0.00158	CcSEcCtD
Zidovudine—Dyspnoea—Temozolomide—brain cancer	0.00024	0.00158	CcSEcCtD
Zidovudine—Somnolence—Temozolomide—brain cancer	0.000239	0.00157	CcSEcCtD
Zidovudine—Constipation—Carmustine—brain cancer	0.000238	0.00157	CcSEcCtD
Zidovudine—Pain—Carmustine—brain cancer	0.000238	0.00157	CcSEcCtD
Zidovudine—Malaise—Etoposide—brain cancer	0.000238	0.00156	CcSEcCtD
Zidovudine—Vertigo—Etoposide—brain cancer	0.000237	0.00156	CcSEcCtD
Zidovudine—Dyspepsia—Temozolomide—brain cancer	0.000237	0.00156	CcSEcCtD
Zidovudine—Leukopenia—Etoposide—brain cancer	0.000236	0.00155	CcSEcCtD
Zidovudine—Diarrhoea—Hydroxyurea—brain cancer	0.000236	0.00155	CcSEcCtD
Zidovudine—Decreased appetite—Temozolomide—brain cancer	0.000234	0.00154	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000232	0.00153	CcSEcCtD
Zidovudine—CYP2C9—endocrine gland—brain cancer	0.000232	0.00615	CbGeAlD
Zidovudine—Fatigue—Temozolomide—brain cancer	0.000232	0.00153	CcSEcCtD
Zidovudine—Loss of consciousness—Etoposide—brain cancer	0.000232	0.00152	CcSEcCtD
Zidovudine—Cough—Etoposide—brain cancer	0.00023	0.00151	CcSEcCtD
Zidovudine—Pain—Temozolomide—brain cancer	0.00023	0.00151	CcSEcCtD
Zidovudine—Constipation—Temozolomide—brain cancer	0.00023	0.00151	CcSEcCtD
Zidovudine—Feeling abnormal—Carmustine—brain cancer	0.00023	0.00151	CcSEcCtD
Zidovudine—Convulsion—Etoposide—brain cancer	0.000229	0.0015	CcSEcCtD
Zidovudine—Dizziness—Hydroxyurea—brain cancer	0.000228	0.0015	CcSEcCtD
Zidovudine—Gastrointestinal pain—Carmustine—brain cancer	0.000228	0.0015	CcSEcCtD
Zidovudine—Chest pain—Etoposide—brain cancer	0.000225	0.00148	CcSEcCtD
Zidovudine—ABCG2—cerebellum—brain cancer	0.000224	0.00593	CbGeAlD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000223	0.00147	CcSEcCtD
Zidovudine—Discomfort—Etoposide—brain cancer	0.000222	0.00146	CcSEcCtD
Zidovudine—Feeling abnormal—Temozolomide—brain cancer	0.000222	0.00146	CcSEcCtD
Zidovudine—Body temperature increased—Carmustine—brain cancer	0.00022	0.00145	CcSEcCtD
Zidovudine—Abdominal pain—Carmustine—brain cancer	0.00022	0.00145	CcSEcCtD
Zidovudine—Gastrointestinal pain—Temozolomide—brain cancer	0.00022	0.00145	CcSEcCtD
Zidovudine—Vomiting—Hydroxyurea—brain cancer	0.000219	0.00144	CcSEcCtD
Zidovudine—Rash—Hydroxyurea—brain cancer	0.000217	0.00143	CcSEcCtD
Zidovudine—Confusional state—Etoposide—brain cancer	0.000217	0.00143	CcSEcCtD
Zidovudine—Dermatitis—Hydroxyurea—brain cancer	0.000217	0.00143	CcSEcCtD
Zidovudine—Headache—Hydroxyurea—brain cancer	0.000216	0.00142	CcSEcCtD
Zidovudine—Anaphylactic shock—Etoposide—brain cancer	0.000215	0.00142	CcSEcCtD
Zidovudine—Urticaria—Temozolomide—brain cancer	0.000214	0.00141	CcSEcCtD
Zidovudine—Abdominal pain—Temozolomide—brain cancer	0.000213	0.0014	CcSEcCtD
Zidovudine—Body temperature increased—Temozolomide—brain cancer	0.000213	0.0014	CcSEcCtD
Zidovudine—Thrombocytopenia—Etoposide—brain cancer	0.000211	0.00139	CcSEcCtD
Zidovudine—Skin disorder—Etoposide—brain cancer	0.000209	0.00138	CcSEcCtD
Zidovudine—Hyperhidrosis—Etoposide—brain cancer	0.000208	0.00137	CcSEcCtD
Zidovudine—Anorexia—Etoposide—brain cancer	0.000205	0.00135	CcSEcCtD
Zidovudine—Nausea—Hydroxyurea—brain cancer	0.000205	0.00135	CcSEcCtD
Zidovudine—Asthenia—Carmustine—brain cancer	0.0002	0.00131	CcSEcCtD
Zidovudine—ABCB1—telencephalon—brain cancer	0.000199	0.00526	CbGeAlD
Zidovudine—Paraesthesia—Etoposide—brain cancer	0.000193	0.00127	CcSEcCtD
Zidovudine—Asthenia—Temozolomide—brain cancer	0.000193	0.00127	CcSEcCtD
Zidovudine—Dyspnoea—Etoposide—brain cancer	0.000192	0.00126	CcSEcCtD
Zidovudine—Somnolence—Etoposide—brain cancer	0.000191	0.00126	CcSEcCtD
Zidovudine—Diarrhoea—Carmustine—brain cancer	0.000191	0.00125	CcSEcCtD
Zidovudine—Pruritus—Temozolomide—brain cancer	0.00019	0.00125	CcSEcCtD
Zidovudine—Decreased appetite—Etoposide—brain cancer	0.000187	0.00123	CcSEcCtD
Zidovudine—CYP2C8—brain—brain cancer	0.000187	0.00496	CbGeAlD
Zidovudine—Gastrointestinal disorder—Etoposide—brain cancer	0.000186	0.00122	CcSEcCtD
Zidovudine—Fatigue—Etoposide—brain cancer	0.000186	0.00122	CcSEcCtD
Zidovudine—Dizziness—Carmustine—brain cancer	0.000184	0.00121	CcSEcCtD
Zidovudine—Pain—Etoposide—brain cancer	0.000184	0.00121	CcSEcCtD
Zidovudine—Constipation—Etoposide—brain cancer	0.000184	0.00121	CcSEcCtD
Zidovudine—Diarrhoea—Temozolomide—brain cancer	0.000184	0.00121	CcSEcCtD
Zidovudine—ABCG2—brain—brain cancer	0.000182	0.00482	CbGeAlD
Zidovudine—Dizziness—Temozolomide—brain cancer	0.000178	0.00117	CcSEcCtD
Zidovudine—Feeling abnormal—Etoposide—brain cancer	0.000177	0.00117	CcSEcCtD
Zidovudine—Vomiting—Carmustine—brain cancer	0.000177	0.00116	CcSEcCtD
Zidovudine—CYP3A4—endocrine gland—brain cancer	0.000177	0.00469	CbGeAlD
Zidovudine—Gastrointestinal pain—Etoposide—brain cancer	0.000176	0.00116	CcSEcCtD
Zidovudine—Rash—Carmustine—brain cancer	0.000176	0.00115	CcSEcCtD
Zidovudine—Dermatitis—Carmustine—brain cancer	0.000175	0.00115	CcSEcCtD
Zidovudine—Headache—Carmustine—brain cancer	0.000174	0.00115	CcSEcCtD
Zidovudine—Vomiting—Temozolomide—brain cancer	0.000171	0.00112	CcSEcCtD
Zidovudine—Urticaria—Etoposide—brain cancer	0.000171	0.00112	CcSEcCtD
Zidovudine—Abdominal pain—Etoposide—brain cancer	0.00017	0.00112	CcSEcCtD
Zidovudine—Body temperature increased—Etoposide—brain cancer	0.00017	0.00112	CcSEcCtD
Zidovudine—Rash—Temozolomide—brain cancer	0.00017	0.00112	CcSEcCtD
Zidovudine—Dermatitis—Temozolomide—brain cancer	0.00017	0.00111	CcSEcCtD
Zidovudine—Headache—Temozolomide—brain cancer	0.000169	0.00111	CcSEcCtD
Zidovudine—ABCB1—gonad—brain cancer	0.000166	0.00439	CbGeAlD
Zidovudine—Nausea—Carmustine—brain cancer	0.000165	0.00109	CcSEcCtD
Zidovudine—ABCB1—pituitary gland—brain cancer	0.000162	0.00429	CbGeAlD
Zidovudine—Nausea—Temozolomide—brain cancer	0.00016	0.00105	CcSEcCtD
Zidovudine—CYP3A4—central nervous system—brain cancer	0.000159	0.00423	CbGeAlD
Zidovudine—ABCB1—medulla oblongata—brain cancer	0.000156	0.00414	CbGeAlD
Zidovudine—TERT—Signaling by Wnt—APC—brain cancer	0.000155	0.00236	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—MPL—brain cancer	0.000155	0.00235	CbGpPWpGaD
Zidovudine—Asthenia—Etoposide—brain cancer	0.000155	0.00102	CcSEcCtD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000154	0.00234	CbGpPWpGaD
Zidovudine—TK1—Metabolism—BSG—brain cancer	0.000154	0.00234	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTCH2—brain cancer	0.000153	0.00233	CbGpPWpGaD
Zidovudine—Pruritus—Etoposide—brain cancer	0.000152	0.001	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—HES5—brain cancer	0.000148	0.00226	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—S100A10—brain cancer	0.000148	0.00226	CbGpPWpGaD
Zidovudine—Diarrhoea—Etoposide—brain cancer	0.000147	0.000969	CcSEcCtD
Zidovudine—TERT—Cell Cycle—BRCA2—brain cancer	0.000144	0.0022	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—STRADA—brain cancer	0.000144	0.00219	CbGpPWpGaD
Zidovudine—ABCB1—midbrain—brain cancer	0.000143	0.00378	CbGeAlD
Zidovudine—TERT—Disease—IDH1—brain cancer	0.000143	0.00217	CbGpPWpGaD
Zidovudine—Dizziness—Etoposide—brain cancer	0.000142	0.000936	CcSEcCtD
Zidovudine—TERT—TCF dependent signaling in response to WNT—CTNNB1—brain cancer	0.000142	0.00216	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—TP53—brain cancer	0.000141	0.00215	CbGpPWpGaD
Zidovudine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00014	0.00214	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CCNE1—brain cancer	0.00014	0.00213	CbGpPWpGaD
Zidovudine—ABCB1—spinal cord—brain cancer	0.000139	0.00369	CbGeAlD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—CTNNB1—brain cancer	0.000138	0.0021	CbGpPWpGaD
Zidovudine—Vomiting—Etoposide—brain cancer	0.000137	0.0009	CcSEcCtD
Zidovudine—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000136	0.00207	CbGpPWpGaD
Zidovudine—Rash—Etoposide—brain cancer	0.000136	0.000893	CcSEcCtD
Zidovudine—Dermatitis—Etoposide—brain cancer	0.000136	0.000892	CcSEcCtD
Zidovudine—TERT—Disease—HEY1—brain cancer	0.000135	0.00206	CbGpPWpGaD
Zidovudine—Headache—Etoposide—brain cancer	0.000135	0.000887	CcSEcCtD
Zidovudine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000134	0.00204	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000134	0.00204	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000133	0.00202	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000133	0.00202	CbGpPWpGaD
Zidovudine—TERT—Disease—DLL1—brain cancer	0.000133	0.00202	CbGpPWpGaD
Zidovudine—TK1—Metabolism—IDH1—brain cancer	0.000132	0.00201	CbGpPWpGaD
Zidovudine—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	0.000131	0.00199	CbGpPWpGaD
Zidovudine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000131	0.00199	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000128	0.00195	CbGpPWpGaD
Zidovudine—TERT—Signaling by WNT in cancer—CTNNB1—brain cancer	0.000128	0.00195	CbGpPWpGaD
Zidovudine—Nausea—Etoposide—brain cancer	0.000128	0.000841	CcSEcCtD
Zidovudine—ABCC5—Disease—DTX2—brain cancer	0.000127	0.00193	CbGpPWpGaD
Zidovudine—ABCB1—endocrine gland—brain cancer	0.000125	0.00332	CbGeAlD
Zidovudine—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000125	0.0019	CbGpPWpGaD
Zidovudine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000125	0.00189	CbGpPWpGaD
Zidovudine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000124	0.00188	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—PCNA—brain cancer	0.000124	0.00188	CbGpPWpGaD
Zidovudine—ABCB1—head—brain cancer	0.000124	0.00328	CbGeAlD
Zidovudine—TERT—Signaling Pathways—ABR—brain cancer	0.00012	0.00183	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000118	0.0018	CbGpPWpGaD
Zidovudine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000117	0.00178	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GLI2—brain cancer	0.000116	0.00177	CbGpPWpGaD
Zidovudine—TERT—TCF dependent signaling in response to WNT—MYC—brain cancer	0.000115	0.00175	CbGpPWpGaD
Zidovudine—ABCB1—central nervous system—brain cancer	0.000113	0.00299	CbGeAlD
Zidovudine—TERT—Disease—SHH—brain cancer	0.000113	0.00171	CbGpPWpGaD
Zidovudine—TERT—Disease—ENO2—brain cancer	0.000113	0.00171	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000112	0.0017	CbGpPWpGaD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—MYC—brain cancer	0.000112	0.0017	CbGpPWpGaD
Zidovudine—ABCB1—cerebellum—brain cancer	0.00011	0.00292	CbGeAlD
Zidovudine—TERT—Signaling Pathways—GLI1—brain cancer	0.000109	0.00166	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000108	0.00164	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDK4—brain cancer	0.000107	0.00163	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—CTNNB1—brain cancer	0.000105	0.0016	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—BSG—brain cancer	0.000105	0.00159	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ENO2—brain cancer	0.000104	0.00159	CbGpPWpGaD
Zidovudine—TERT—Signaling by WNT in cancer—MYC—brain cancer	0.000104	0.00158	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SUFU—brain cancer	0.000104	0.00157	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—SOD2—brain cancer	0.000102	0.00155	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GFAP—brain cancer	9.99e-05	0.00152	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	9.96e-05	0.00151	CbGpPWpGaD
Zidovudine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	9.59e-05	0.00146	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HEY1—brain cancer	9.47e-05	0.00144	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	9.42e-05	0.00143	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HES5—brain cancer	9.33e-05	0.00142	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	9.32e-05	0.00142	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—DLL1—brain cancer	9.28e-05	0.00141	CbGpPWpGaD
Zidovudine—ABCB1—brain—brain cancer	8.96e-05	0.00238	CbGeAlD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	8.72e-05	0.00133	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—TRPC6—brain cancer	8.56e-05	0.0013	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—MYC—brain cancer	8.54e-05	0.0013	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—VEGFA—brain cancer	8.52e-05	0.0013	CbGpPWpGaD
Zidovudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	8.51e-05	0.00129	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDKN2A—brain cancer	8.18e-05	0.00124	CbGpPWpGaD
Zidovudine—TERT—Disease—VAV1—brain cancer	8.14e-05	0.00124	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	8.12e-05	0.00123	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	8.11e-05	0.00123	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—SOD2—brain cancer	8.08e-05	0.00123	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SHH—brain cancer	7.89e-05	0.0012	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TRPC6—brain cancer	7.61e-05	0.00116	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SMO—brain cancer	7.48e-05	0.00114	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PTCH1—brain cancer	7.48e-05	0.00114	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	7.36e-05	0.00112	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	7.36e-05	0.00112	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	7.29e-05	0.00111	CbGpPWpGaD
Zidovudine—ALB—Vitamin B12 Metabolism—RELA—brain cancer	7.23e-05	0.0011	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CYP2C9—brain cancer	7.19e-05	0.00109	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.12e-05	0.00108	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.02e-05	0.00107	CbGpPWpGaD
Zidovudine—TERT—Disease—HES1—brain cancer	7e-05	0.00107	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—MPL—brain cancer	7e-05	0.00106	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CCND1—brain cancer	6.91e-05	0.00105	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TRPC6—brain cancer	6.85e-05	0.00104	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—S100A10—brain cancer	6.71e-05	0.00102	CbGpPWpGaD
Zidovudine—TERT—Disease—PDGFRA—brain cancer	6.67e-05	0.00101	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.32e-05	0.000961	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IDH1—brain cancer	6.28e-05	0.000955	CbGpPWpGaD
Zidovudine—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	6.26e-05	0.000952	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	6.19e-05	0.000941	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	6.14e-05	0.000934	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—BSG—brain cancer	6.11e-05	0.00093	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	6.01e-05	0.000915	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NOTCH2—brain cancer	5.98e-05	0.00091	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HEY1—brain cancer	5.95e-05	0.000905	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	5.93e-05	0.000902	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—RELA—brain cancer	5.88e-05	0.000894	CbGpPWpGaD
Zidovudine—TERT—Disease—IRS2—brain cancer	5.86e-05	0.00089	CbGpPWpGaD
Zidovudine—ABCC5—Disease—DLL1—brain cancer	5.84e-05	0.000887	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.82e-05	0.000885	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	5.81e-05	0.000884	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VAV1—brain cancer	5.7e-05	0.000867	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MYC—brain cancer	5.55e-05	0.000843	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP2C9—brain cancer	5.3e-05	0.000806	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—IL2—brain cancer	5.29e-05	0.000805	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—IDH1—brain cancer	5.26e-05	0.000799	CbGpPWpGaD
Zidovudine—TERT—Disease—APC—brain cancer	5.17e-05	0.000786	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	5.16e-05	0.000785	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VAV1—brain cancer	5.13e-05	0.000781	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.09e-05	0.000774	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	5.09e-05	0.000774	CbGpPWpGaD
Zidovudine—ABCC4—Ectoderm Differentiation—MYC—brain cancer	5.07e-05	0.000771	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.06e-05	0.00077	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ENO2—brain cancer	4.96e-05	0.000755	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SHH—brain cancer	4.96e-05	0.000755	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.91e-05	0.000747	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HES1—brain cancer	4.9e-05	0.000746	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PIK3CG—brain cancer	4.79e-05	0.000728	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—BSG—brain cancer	4.73e-05	0.000719	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PDGFRA—brain cancer	4.67e-05	0.00071	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—RELA—brain cancer	4.67e-05	0.00071	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.6e-05	0.0007	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—brain cancer	4.56e-05	0.000693	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.55e-05	0.000691	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SPP1—brain cancer	4.53e-05	0.000689	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—BSG—brain cancer	4.51e-05	0.000685	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	4.51e-05	0.000685	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	4.45e-05	0.000677	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.35e-05	0.000661	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.3e-05	0.000654	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ENO2—brain cancer	4.16e-05	0.000632	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IRS2—brain cancer	4.1e-05	0.000623	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.04e-05	0.000614	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—IL2—brain cancer	4.02e-05	0.000611	CbGpPWpGaD
Zidovudine—TERT—Disease—ERBB2—brain cancer	4.02e-05	0.000611	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.96e-05	0.000602	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.94e-05	0.000599	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.91e-05	0.000594	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—IDH1—brain cancer	3.88e-05	0.000589	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—VEGFA—brain cancer	3.86e-05	0.000587	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.78e-05	0.000575	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.72e-05	0.000566	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.7e-05	0.000563	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	3.67e-05	0.000559	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP2C9—brain cancer	3.65e-05	0.000556	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.63e-05	0.000552	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—APC—brain cancer	3.62e-05	0.000551	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CG—brain cancer	3.62e-05	0.000551	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP2C9—brain cancer	3.62e-05	0.00055	CbGpPWpGaD
Zidovudine—ABCC5—Disease—VAV1—brain cancer	3.59e-05	0.000545	CbGpPWpGaD
Zidovudine—TERT—Disease—CTNNB1—brain cancer	3.51e-05	0.000534	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.46e-05	0.000526	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.41e-05	0.000519	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—brain cancer	3.4e-05	0.000517	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.32e-05	0.000505	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP2C9—brain cancer	3.32e-05	0.000505	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CG—brain cancer	3.26e-05	0.000496	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—BSG—brain cancer	3.11e-05	0.000473	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TRPC6—brain cancer	3.1e-05	0.000471	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HES1—brain cancer	3.08e-05	0.000469	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—BSG—brain cancer	3.08e-05	0.000468	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ENO2—brain cancer	3.06e-05	0.000466	CbGpPWpGaD
Zidovudine—TERT—Disease—STAT3—brain cancer	3.06e-05	0.000466	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.03e-05	0.000461	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.99e-05	0.000455	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PDGFRA—brain cancer	2.94e-05	0.000446	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	2.86e-05	0.000435	CbGpPWpGaD
Zidovudine—TERT—Disease—MYC—brain cancer	2.85e-05	0.000433	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RELA—brain cancer	2.83e-05	0.00043	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—BSG—brain cancer	2.82e-05	0.000429	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.82e-05	0.000428	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ERBB2—brain cancer	2.81e-05	0.000428	CbGpPWpGaD
Zidovudine—TERT—Disease—EGFR—brain cancer	2.78e-05	0.000423	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	2.68e-05	0.000408	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—IDH1—brain cancer	2.67e-05	0.000406	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—IDH1—brain cancer	2.64e-05	0.000402	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IRS2—brain cancer	2.58e-05	0.000392	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL2—brain cancer	2.55e-05	0.000387	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCND1—brain cancer	2.48e-05	0.000378	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CTNNB1—brain cancer	2.46e-05	0.000374	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—IDH1—brain cancer	2.43e-05	0.000369	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.35e-05	0.000358	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VAV1—brain cancer	2.32e-05	0.000353	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IL2—brain cancer	2.29e-05	0.000349	CbGpPWpGaD
Zidovudine—ABCC5—Disease—APC—brain cancer	2.28e-05	0.000346	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.27e-05	0.000345	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP2C9—brain cancer	2.26e-05	0.000343	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.19e-05	0.000333	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—brain cancer	2.17e-05	0.000329	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—STAT3—brain cancer	2.14e-05	0.000326	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ENO2—brain cancer	2.11e-05	0.000321	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ENO2—brain cancer	2.09e-05	0.000318	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.02e-05	0.000308	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	2.01e-05	0.000306	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MYC—brain cancer	1.99e-05	0.000303	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2C9—brain cancer	1.98e-05	0.0003	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—brain cancer	1.95e-05	0.000296	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EGFR—brain cancer	1.95e-05	0.000296	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.93e-05	0.000294	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—BSG—brain cancer	1.93e-05	0.000293	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ENO2—brain cancer	1.92e-05	0.000292	CbGpPWpGaD
Zidovudine—ALB—Metabolism—BSG—brain cancer	1.92e-05	0.000292	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.91e-05	0.000291	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CG—brain cancer	1.91e-05	0.00029	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—brain cancer	1.77e-05	0.000269	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—BSG—brain cancer	1.72e-05	0.000262	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.71e-05	0.00026	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.68e-05	0.000256	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—BSG—brain cancer	1.68e-05	0.000255	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—IDH1—brain cancer	1.66e-05	0.000252	CbGpPWpGaD
Zidovudine—ALB—Metabolism—IDH1—brain cancer	1.65e-05	0.000251	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—brain cancer	1.64e-05	0.000249	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—BSG—brain cancer	1.57e-05	0.000239	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.55e-05	0.000236	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CTNNB1—brain cancer	1.55e-05	0.000235	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.52e-05	0.000231	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—IDH1—brain cancer	1.48e-05	0.000225	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CG—brain cancer	1.47e-05	0.000224	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—brain cancer	1.47e-05	0.000224	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—IDH1—brain cancer	1.44e-05	0.00022	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000214	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.35e-05	0.000205	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—IDH1—brain cancer	1.35e-05	0.000205	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—brain cancer	1.35e-05	0.000205	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000204	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO2—brain cancer	1.31e-05	0.000199	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO2—brain cancer	1.3e-05	0.000198	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.27e-05	0.000194	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—brain cancer	1.25e-05	0.00019	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—brain cancer	1.23e-05	0.000186	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.22e-05	0.000185	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000183	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO2—brain cancer	1.17e-05	0.000178	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO2—brain cancer	1.14e-05	0.000174	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.000167	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO2—brain cancer	1.07e-05	0.000162	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—brain cancer	1.04e-05	0.000158	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BSG—brain cancer	1.04e-05	0.000157	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CG—brain cancer	9.69e-06	0.000147	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CG—brain cancer	9.59e-06	0.000146	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—IDH1—brain cancer	8.9e-06	0.000135	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—brain cancer	8.82e-06	0.000134	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CG—brain cancer	8.8e-06	0.000134	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO2—brain cancer	7.04e-06	0.000107	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—brain cancer	6.66e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CG—brain cancer	6.01e-06	9.14e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CG—brain cancer	5.98e-06	9.09e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.37e-06	8.16e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CG—brain cancer	5.24e-06	7.97e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.89e-06	7.44e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.23e-06	4.91e-05	CbGpPWpGaD
